Press

26 MAY 2020 4DMedical's XV Technology automatically analyses any functional lung impairment from a single X-ray. Credit: Stillwaterising / Wiki Commons. The US Food and Drug Administration (FDA) has granted regulatory clearance to 4DMedical to market its four-dimensional lung imaging process XV Technology. The technology is a software-as-a-service...

TUESDAY, MAY 26, 2020 4DMedical, an Australian medical technology company specializing in medical imaging innovation software, announced today it has received clearance from the U.S. Food & Drug Administration to market its XV Technology™,  a patented four-dimensional lung imaging  process that rapidly and automatically analyses any...

"Our XV Technology™ is a valuable new respiratory diagnostic tool," said 4DMedical founder and CEO, Andreas Fouras, Ph.D. "It provides critical information about the functional and structural state of a patient's lungs in the treatment of illnesses such as COVID-19, asthma, chronic obstructive pulmonary disease, cystic...

May 25, 2020 WOODLAND HILLS, Calif., May 25, 2020 /PRNewswire/ -- 4DMedical, an Australian medical technology company specializing in medical imaging innovation software, announced today it has received clearance from the U.S. Food & Drug Administration to market its XV Technology™,  a patented four-dimensional lung imaging  process that rapidly...

Published: May 25, 2020 WOODLAND HILLS, Calif., May 25, 2020 /PRNewswire/ -- 4DMedical, an Australian medical technology company specializing in medical imaging innovation software, announced today it has received clearance from the U.S. Food & Drug Administration to market its XV Technology™, a patented four-dimensional lung imaging process that rapidly and...

As printed in the The Age Friday 22nd May 2020 Page 27 | Section: BUSINESS   ASX medtech hopeful 4D Medical has joined a pack of Australian start-ups hoping to get a green light from the US Food and Drug Administration (FDA) to market its product in the coronavirus...

4D MEDICAL (FORMERLY 4DX) Melbourne’s 4D says the US Food and Drug Administration has cleared its “four-dimensional” XV lung ventilation analysis software imaging product for sale in the US. 4D said that the XV technology was not intended to replace primary diagnostic tests, such as the molecular...

As printed in The Daily Telegraph, Thursday 30th April 2020 By Charles Miranda A TEAM of Australian scientists has created a groundbreaking “field ventilator” to help combat coronavirus in remote regions of Australia and overseas where hospital emergency resources are limited. And critically they are going into production...